About Pregio Pharma Private Limited
Data last updated:
Pregio Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24297TN2011PTC079939. Its GSTIN is 33AAGCP1812J1ZN (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.32 Cr. It is led by directors Muthuvelayudham Sivakumar (Managing Director) and Sasikumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1035 A New No 11 H – Block 24th Street Anna Nagar West Chennai 600040, Tamil Nadu, India – 600040.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.7 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹77.06 Lakh (net margin 1.8%) and EBITDA of ₹2.33 Cr (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 10% over five years.
The company is associated with 1 brand: Pregio Pharma. As per MCA filings, the company has open charges of ₹12.2 Cr and satisfied charges of ₹8.4 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Samrudh Pharmacare Private Limited with revenue of ₹41.88 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pregiopharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1035 A New No 11 H – Block 24th Street Anna Nagar West Chennai 600040, Tamil Nadu, India – 600040
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pregio Pharma Private Limited
The main business activity of Pregio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pregio Pharma Private Limited FY 2024 filings available
Pregio Pharma Private Limited reported revenue of ₹41.7 Cr (up 34% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pregio Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 34% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pregio Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.33 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹77.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pregio Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pregio Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pregio Pharma Private Limited
Pregio Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Mediart Lifesciences Private Limited | ₹41.86 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Elbrit Life Sciences Private Limited | ₹41.77 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Erode, Tamil Nadu, India |
| Crest Lifesciences Private Limited | ₹41.71 Cr (FY 2025) | •••• | •••• | 397.0% | •••• | Baddi, Himachal Pradesh, India |
| Pregio Pharma Private Limited this company | ₹41.7 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Chennai, Tamil Nadu, India |
| P.B.P Enterprises Private Limited | ₹41.67 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Mumbai, Maharashtra, India |
| Strava Healthcare Private Limited | ₹41.58 Cr (FY 2025) | •••• | •••• | 115.0% | •••• | Ahmedabad, Gujarat, India |
| SSM Formulations Private Limited | ₹41.41 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Hinganghat, Maharashtra, India |
| J M Healthcare Private Limited | ₹41.39 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Chandigarh, India |
| Curium Pharma (India) Private Limited | ₹41.38 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Pregio Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pregio Pharma Private Limited
Auditor information for Pregio Pharma Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Pregio Pharma Private Limited
Pregio Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muthuvelayudham Sivakumar | Managing Director | 30 Mar 2011 | 15 Years 6 Months | Current |
| Sasikumar | Director | 28 Oct 2016 | 9 Years 11 Months | Current |
Ownership and Shareholding of Pregio Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pregio Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | Indian Overseas Bank | ₹8.03 Lakh | Open |
| 28 Jul 2023 | Indian Overseas Bank | ₹12.12 Cr | Open |
| 31 Dec 2019 | The South Indian Bank Limited | ₹4.42 Cr | Satisfied |
| 30 May 2013 | Others | ₹3.98 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Pregio Pharma Private Limited
Pregio Pharma Private Limited has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹2.18 Cr | Investors: 4 individuals |
| Mar 2017 | Funding round | ₹1.48 Cr | Investors: 3 individuals |
| Mar 2016 | Funding round | ₹67.1 Lakh | Investors: 3 individuals |
| May 2012 | Funding round | ₹1.19 Cr | Investors: 4 individuals |
| Jan 2012 | Funding round | ₹10 Lakh | Investors: 2 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Pregio Pharma Private Limited
Pregio Pharma Private Limited has 8 court cases on record: 4 filed by Pregio Pharma, 4 filed against it. 2 cases are pending and 6 are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 2 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed against the company by Scope Ingredients Private Limited | Disposed |
| District court, Mancherial, Telangana | Criminal complaint | Filed against the company by State of Telangana Represented Nu Drugs Inspector, Mancherial District | Pending |
| District court, Krishna, Andhra Pradesh | Criminal complaint | Filed against the company by Ap State | Pending |
| District court, Krishna, Andhra Pradesh | Court case (PRC) | Filed against the company by State of Andhra Pradesh | Disposed |
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Pregio Pharma Private Limited
Pregio Pharma operates one associated brand: Pregio Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing quality medicines including cardiac and anti-diabetics drugs in India. | pregiopharma.in |
Employees and EPFO Compliance at Pregio Pharma Private Limited
Employment history and EPFO contributions of people linked to Pregio Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pregio Pharma Private Limited
Pregio Pharma Private Limited has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Viswanathan Palaniappan ceased to be Company Secretary on 06 Jan 2025.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pregio Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pregio Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pregio Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pregio Pharma Private Limited
Pregio Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCP1812J1ZN | Tamil Nadu | Active | 06 Jul 2021 |
| 34AAGCP1812J1ZL | Puducherry | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pregio Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pregio Pharma Private Limited
Pregio Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2011 (15+ years old) and is registered under CIN U24297TN2011PTC079939.
Pregio Pharma reported revenue of ₹41.7 Cr for FY 2024 (up 34% YoY).
Pregio Pharma has 2 current directors:
- Muthuvelayudham Sivakumar - Managing Director
- Sasikumar - Director
Pregio Pharma reported a net profit of ₹77.06 Lakh (net margin 1.8%) and EBITDA of ₹2.33 Cr (EBITDA margin 5.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pregio Pharma is 26% over three years and 10% over five years. In the latest year (FY 2024) revenue rose 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pregio Pharma is 33AAGCP1812J1ZN, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AAGCP1812J1ZL (Puducherry).
The CIN (Corporate Identification Number) of Pregio Pharma is U24297TN2011PTC079939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pregio Pharma has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Pregio Pharma was incorporated on 30 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
Pregio Pharma has 5 deals on record (5 funding rounds), with disclosed funding of ₹5.62 Cr; the latest was in March 2019.
The peers of Pregio Pharma by revenue are Samrudh Pharmacare Private Limited, Mediart Lifesciences Private Limited, Aap Pharma Technologies India Private Limited, Elbrit Life Sciences Private Limited, Crest Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).